• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES LLC CARPENTIER-EDWARDS PERIMOUNT MAGNA EASE PERICARDIAL BIOPROSTHESIS; REPLACEMENT HEART-VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES LLC CARPENTIER-EDWARDS PERIMOUNT MAGNA EASE PERICARDIAL BIOPROSTHESIS; REPLACEMENT HEART-VALVE Back to Search Results
Model Number 3300TFX
Device Problems Fluid/Blood Leak (1250); Inadequacy of Device Shape and/or Size (1583); Difficult to Open or Close (2921)
Patient Problem Insufficient Information (4580)
Event Date 08/09/2021
Event Type  Injury  
Manufacturer Narrative
The device was not returned to edwards for evaluation.Attempts to retrieve the device and additional information is in process.The device is listed as available.A supplemental mdr will be submitted as new information is received.The cause of the event cannot be determined.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
Edwards received information a 23mm 3300tfx aortic valve was explanted after implant due to intravalvular leak (one of the leaflets appeared to not be functioning well) and due to valve size being too small.Patient underwent aortic valve replacement with 25mm 3300tfx and left atrial appendage ligation with atrial clip.Surgeon feels this particular valve was mis-sized by manufacturer.Tee guidance confirmed good function, no perivalvular leak.Once protamine was administered and patient was decannulated it was found there was intravalvular leak noted and one of the leaflets was not functioning well.The valve was explanted and found to look normal and have no evidence of leaflet tethering or structural problem.The explanted device was replaced with a 25mm 3300tfx.The patient remained in icu on ventilator- no surgical complications.
 
Manufacturer Narrative
H10: additional manufacturer narrative: updated section: h3 (device evaluated by manufacturer), and h6 (type of investigation) product evaluation: the customer report of intravalvular leak and valve sizing issues could not be confirmed through visual observations.
 
Manufacturer Narrative
H10.Additional manufacturer narrative: the device history record was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.H3.Evaluation: customer report of intervalvular leak and valve sizing issues could not be confirmed through visual observations.X-ray demonstrated wireform intact.All three leaflets had serrated mechanical damage on the outflow surfaces.Suture holes were visible around the sewing ring.Sewing ring was cut around commissure 3.The external sewing ring diameter measured to be approximately 28 mm and the internal stent diameter measured to be approximately 22 mm.No intraoperative echocardiogram was provided, thus, the behavior reported in vivo could not be confirmed.A review of the manufacturing and inspection records related to this device was completed, and the results show that the device met all manufacturing specifications and inspections.The reported surgeon feels this particular valve was mis-sized by manufacturer was not confirmed.Sizing is a function of the prosthetic valve and the adjacent anatomy.Since only the valve was returned to edwards, no statement can be made concerning the sizing of the valve.Functional testing was performed in a pulse duplicator under simulated normal physiological conditions and in a steady backflow leakage tester.The leaflets all functioned well, opening and closing normally.The total regurgitant fraction (trf) of the valve as received was 8.9 percent, which is lower than the 10 percent allowed for a valve this size per iso 5840-2:2021.No visible central leakage pathway was evident during pulsatile testing.Therefore, the leakage measured in the pulsatile flow test is likely through the damaged areas of the sewing ring and/or around the valve.The reported intervalvular leak was not reproduced in the standardized pulsatile testing performed at edwards under simulated normal physiological conditions.The results from in vitro testing may be different from those obtained in the operating room due to hemodynamic and environmental differences.Per ifu, the specification for the external sewing ring diameter of 3300tfx23mm is 28mm, and the internal stent diameter is 22mm.Measurements performed in product evaluation align with nominal measurements provided in the ifu.Therefore, the customer allegation that the valve was not manufactured to the correct size was not confirmed.A definitive root cause for the reported intervalvular leak in vivo could not be conclusively determined, however it may have been due to patient and/or procedural factors.Based on the information available, a manufacturing defect has not been confirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARPENTIER-EDWARDS PERIMOUNT MAGNA EASE PERICARDIAL BIOPROSTHESIS
Type of Device
REPLACEMENT HEART-VALVE
Manufacturer (Section D)
EDWARDS LIFESCIENCES LLC
one edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer Contact
gail warner
1 edwards way
irvine, CA 92614
9492504062
MDR Report Key12451289
MDR Text Key273100206
Report Number2015691-2021-05097
Device Sequence Number1
Product Code DYE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860057
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 01/31/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/09/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number3300TFX
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received01/06/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/23/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Other;
Patient Age72 YR
Patient SexFemale
Patient Weight52 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-